By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer will sell, service, and provide support for Roche's NimbleGen CGX microarray workflow for most countries outside the US under a supply agreement deal announced today by the two companies.

Roche will continue to sell the workflow in the US and other select markets under the terms of the deal, which takes effect in January.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.